144 related articles for article (PubMed ID: 29621974)
1. Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale.
Członkowska A; Litwin T; Dzieżyc K; Karliński M; Bring J; Bjartmar C
BMC Neurol; 2018 Apr; 18(1):34. PubMed ID: 29621974
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research.
Karantzoulis S; Heuer K; Sparling N; Meltzer B; Teynor M
Adv Ther; 2024 May; 41(5):2070-2082. PubMed ID: 38573483
[TBL] [Abstract][Full Text] [Related]
3. Assessment and factors affecting quality of life among patients with Wilson's disease.
Zhan T; Guan Y; Sun C; Wang L; Wang Y; Li X
Sci Rep; 2024 Apr; 14(1):8636. PubMed ID: 38622213
[TBL] [Abstract][Full Text] [Related]
4. Tackling the neurological manifestations in Wilson's disease - currently available treatment options.
Litwin T; Dusek P; Antos A; Członkowska A; Bembenek J
Expert Rev Neurother; 2023; 23(12):1249-1259. PubMed ID: 37842984
[TBL] [Abstract][Full Text] [Related]
5. Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.
Li LY; Yang WM; Chen HZ; Wu YH; Fang X; Zhang J; Wang Z; Han YS; Wang Y
PLoS One; 2015; 10(4):e0124569. PubMed ID: 25910248
[TBL] [Abstract][Full Text] [Related]
6. Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component.
Ortiz JF; Morillo Cox Á; Tambo W; Eskander N; Wirth M; Valdez M; Niño M
Cureus; 2020 Nov; 12(11):e11509. PubMed ID: 33354453
[TBL] [Abstract][Full Text] [Related]
7. A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson's disease.
Han H; Zhao D; Fang X; Yang W; Wang M; Liu Q; Wang L; Ji Z; Zhang J; Hou Z; Hua L; Wang Y; Wu L
Expert Rev Vaccines; 2023; 22(1):1185-1195. PubMed ID: 38010939
[TBL] [Abstract][Full Text] [Related]
8. Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
Shribman S; Heller C; Burrows M; Heslegrave A; Swift I; Foiani MS; Gillett GT; Tsochatzis EA; Rowe JB; Gerhard A; Butler CR; Masellis M; Bremner F; Martin A; Jung L; Cook P; Zetterberg H; Bandmann O; Rohrer JD; Warner TT
Mov Disord; 2021 Feb; 36(2):503-508. PubMed ID: 33078859
[TBL] [Abstract][Full Text] [Related]
9. Characterization of renal damage in Wilson's disease-Detailed analysis of 20 Chinese cases.
Jin S; Sun Z; Fang X; Yang W
Med Clin (Barc); 2024 Jun; ():. PubMed ID: 38890098
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson Disease.
Camarata MA; Ala A; Coskun AK; Deng Y; Gonzalez-Peralta RP; Maciejewski KR; Patel A; Rubman S; To U; Tomlin R; Schilsky ML; Zimbrean PC
J Acad Consult Liaison Psychiatry; 2021; 62(5):528-537. PubMed ID: 34044196
[TBL] [Abstract][Full Text] [Related]
11. A rare presentation of Wilson disease with neurological symptoms: Case report and genetic analysis.
Elendu C; Amaechi DC; Jingwa KA; Elendu TC
Medicine (Baltimore); 2024 Feb; 103(5):e37099. PubMed ID: 38306527
[TBL] [Abstract][Full Text] [Related]
12. A study of linear measurement and clinical correlation of brain atrophy in Wilson's disease.
Wang Y; Xuan H; Zhao T; Li X; Li S; Hu W
Front Hum Neurosci; 2023; 17():1142082. PubMed ID: 37056963
[TBL] [Abstract][Full Text] [Related]
13. Sexual dysfunction in Wilson disease: Prevalence and influencing factors.
Zhu L; Song B; Han YS; Xu Y; Xun-Wang ; Xue BC; Han YZ; Yang RM
J Clin Neurosci; 2023 Dec; 118():117-122. PubMed ID: 37922727
[TBL] [Abstract][Full Text] [Related]
14. Unusual psychotic presentation after discontinuation of treatment in a patient with Wilson's disease: a case report.
Lappas AS; Jan F
Clin Schizophr Relat Psychoses; 2016 Dec; ():. PubMed ID: 27996315
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for wilson disease: Current knowledge and future perspectives.
Ferrarese A; Cazzagon N; Burra P
Liver Transpl; 2024 Jun; ():. PubMed ID: 38899966
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging pontine signal abnormality in neurological Wilson disease: A case report.
Gajurel BP; Karki S; Parajuli A; Khanal SB
Clin Case Rep; 2023 Sep; 11(9):e7851. PubMed ID: 37636888
[TBL] [Abstract][Full Text] [Related]
17. Wilson disease - the impact of hyperimmunity on disease activity: A case report.
Stremmel W; Longerich T; Liere R; Vacata V; van Helden J; Weiskirchen R
World J Clin Cases; 2021 Feb; 9(6):1386-1393. PubMed ID: 33644206
[TBL] [Abstract][Full Text] [Related]
18. Elderly-onset severe parkinsonism in Wilson disease: A case report.
Li KF; Li J; Liao YP; Zhu SH; Chhetri JK; Chen HZ; Yang WM
Parkinsonism Relat Disord; 2023 Nov; ():105924. PubMed ID: 37945393
[No Abstract] [Full Text] [Related]
19. Early neurological worsening in Wilson disease: The need for an evidence-based definition.
Litwin T; Członkowska A; Smolinski L
J Hepatol; 2023 Dec; 79(6):e241-e242. PubMed ID: 37392837
[No Abstract] [Full Text] [Related]
20. Reply to: "Early neurological worsening in Wilson disease: The need for an evidence-based definition".
Mohr I; Poujois A; Ala A; Weiss KH
J Hepatol; 2023 Dec; 79(6):e243. PubMed ID: 37714382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
